High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.
By T. Pedersen, O. Faergeman, J. Kastelein, A. Olsson, M. Tikkanen, I. Holme, M. Larsen, F. Bendiksen, Christina Lindahl, M. Szarek and 1 more. Journal of the American Medical Association (JAMA), 2005
1,602 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/13a3381864b4e04a72aec64945ec0d9fa9a28c60
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.